Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer's drug Leqembi. Biogen had 8,725 employees worldwide as of the end of last year. The layoffs are part of the…
#leqembi #biogen #als #chrisviehbacher #wellsfargo #mohitbansal